CEPI to invest up to $80M on ChAdOx vaccine platform, previously used in AstraZeneca/Oxford Covid jab
The Coalition for Epidemic Preparedness Innovations (CEPI) is allocating up to $80 million for the University of Oxford to develop vaccine …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
